2.65
price up icon35.90%   0.70
after-market Dopo l'orario di chiusura: 2.72 0.07 +2.64%
loading

Indaptus Therapeutics Inc Borsa (INDP) Ultime notizie

pulisher
03:00 AM

What Does the Market Think About Indaptus Therapeutics Inc? - Benzinga

03:00 AM
pulisher
Dec 24, 2025

Indaptus Therapeutics Inc. (INDP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Dec 24, 2025
pulisher
Dec 24, 2025

Indaptus Therapeutics Inc.: Are They Ready for Takeoff? - StocksToTrade

Dec 24, 2025
pulisher
Dec 24, 2025

Biotech Stocks To Keep An Eye OnDecember 24th - MarketBeat

Dec 24, 2025
pulisher
Dec 24, 2025

Indaptus Therapeutics, Inc.Common Stock (Nasdaq:INDP) Stock Quote - FinancialContent

Dec 24, 2025
pulisher
Dec 24, 2025

Is It Too Late to Buy INDP Stock? - timothysykes.com

Dec 24, 2025
pulisher
Dec 24, 2025

Indaptus Therapeutics (INDP) Stock in Focus on Dec. 24, 2025: $6M Financing, Leadership Reset, and the Dilution Question - ts2.tech

Dec 24, 2025
pulisher
Dec 24, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Dec 24, 2025
pulisher
Dec 23, 2025

Why Did Indaptus Therapeutics Surge 64% In After-Hours Trading? - Benzinga

Dec 23, 2025
pulisher
Dec 23, 2025

Indaptus Therapeutics, Uipath, Trinity Biotech, Sable Offshore And McDonald's: Why These 5 Stocks Are On Investors' Radars Today - Benzinga

Dec 23, 2025
pulisher
Dec 23, 2025

Indaptus Therapeutics : Initial Statement of Beneficial Ownership (Form 3) - marketscreener.com

Dec 23, 2025
pulisher
Dec 23, 2025

Trending Stocks Today | Indaptus Therapeutics Soars 52.9% Post-Market - 富途牛牛

Dec 23, 2025
pulisher
Dec 23, 2025

Indaptus Therapeutics Inc appoints David Lazar as co-chief executive officer - marketscreener.com

Dec 23, 2025
pulisher
Dec 23, 2025

Indaptus Therapeutics Signs Securities Purchase Agreement With David Lazar - TradingView — Track All Markets

Dec 23, 2025
pulisher
Dec 23, 2025

[8-K] Indaptus Therapeutics, Inc. Reports Material Event | INDP SEC FilingForm 8-K - Stock Titan

Dec 23, 2025
pulisher
Dec 22, 2025

Indaptus Therapeutics, Inc. announced that it has received $6 million in funding - marketscreener.com

Dec 22, 2025
pulisher
Dec 21, 2025

Indaptus Therapeutics, Inc. announced that it expects to receive $6 million in funding - marketscreener.com

Dec 21, 2025
pulisher
Dec 21, 2025

Can Indaptus Therapeutics Inc. stock hit record highs again2025 Top Gainers & Precise Entry and Exit Recommendations - Улправда

Dec 21, 2025
pulisher
Dec 20, 2025

How buybacks impact Indaptus Therapeutics Inc. stock valueTrade Analysis Summary & AI Forecast for Swing Trade Picks - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Breakout Move: Is Indaptus Therapeutics Inc stock attractive for hedge fundsJuly 2025 Patterns & AI Enhanced Market Trend Forecasts - moha.gov.vn

Dec 20, 2025
pulisher
Dec 19, 2025

Will Indaptus Therapeutics Inc. stock outperform value stocksShort Setup & Weekly High Potential Stock Alerts - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

How analysts rate Indaptus Therapeutics Inc. stock todayMarket Risk Report & Scalable Portfolio Growth Methods - Bölüm Sonu Canavarı

Dec 19, 2025
pulisher
Dec 19, 2025

Is Indaptus Therapeutics Inc. stock a good choice for value investors2025 Valuation Update & Long Hold Capital Preservation Plans - ulpravda.ru

Dec 19, 2025
pulisher
Dec 18, 2025

Published on: 2025-12-19 01:13:33 - moha.gov.vn

Dec 18, 2025
pulisher
Dec 18, 2025

Indaptus Therapeutics Earnings Notes - Trefis

Dec 18, 2025
pulisher
Dec 06, 2025

Indaptus Therapeutics (NASDAQ:INDP) Downgraded by Wall Street Zen to “Sell” - Defense World

Dec 06, 2025
pulisher
Nov 29, 2025

Indaptus Therapeutics (NASDAQ:INDP) Rating Increased to Hold at Wall Street Zen - Defense World

Nov 29, 2025
pulisher
Nov 28, 2025

Pullback Watch: How buybacks impact Indaptus Therapeutics Inc. stock valueMarket Weekly Review & Risk Controlled Stock Pick Alerts - moha.gov.vn

Nov 28, 2025
pulisher
Nov 24, 2025

Nuvalent (NUVL) Receives a New Rating from Truist Financial - The Globe and Mail

Nov 24, 2025
pulisher
Nov 20, 2025

Indaptus Therapeutics (INDP) Price Target Decreased by 60.00% to 10.20 - MSN

Nov 20, 2025
pulisher
Nov 19, 2025

Volume spikes in Indaptus Therapeutics Inc. stock – what they meanEarnings Risk Summary & Smart Investment Allocation Insights - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Ranking Indaptus Therapeutics Inc. among high performing stocks via toolsTrade Risk Assessment & Low Volatility Stock Suggestions - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why Indaptus Therapeutics Inc. stock could see breakout soonPortfolio Return Report & Low Volatility Stock Recommendations - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Indaptus Therapeutics Inc. rebound enough to break evenJuly 2025 Recap & Expert Approved Momentum Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How high can Indaptus Therapeutics Inc. stock go2025 Technical Patterns & Real-Time Volume Analysis Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What momentum indicators show for Indaptus Therapeutics Inc. stockMarket Sentiment Summary & Daily Profit Focused Screening - newser.com

Nov 19, 2025
pulisher
Nov 17, 2025

Indaptus Therapeutics 3Q Research and Development Expenses About $1.52M >INDP - 富途牛牛

Nov 17, 2025
pulisher
Nov 17, 2025

Indaptus Therapeutics Chief Scientific Officer Dr. Michael Newman to Present at the Donor Selection & Cell Source Summit - The Manila Times

Nov 17, 2025
pulisher
Nov 17, 2025

Why Is Indaptus Therapeutics, Inc. (INDP) Stock Down Today? - Meyka

Nov 17, 2025
pulisher
Nov 17, 2025

Indaptus (Nasdaq: INDP) showcases Decoy20 to tackle donor cell variability - Stock Titan

Nov 17, 2025
pulisher
Nov 17, 2025

Volatility clustering patterns for Indaptus Therapeutics Inc.Weekly Trade Analysis & Reliable Intraday Trade Alerts - newser.com

Nov 17, 2025
pulisher
Nov 16, 2025

Does Indaptus Therapeutics Inc. fit your quant trading modelJuly 2025 Short Interest & Weekly High Conviction Trade Ideas - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Why retail investors pile into Indaptus Therapeutics Inc. stockWeekly Gains Report & Capital Efficiency Focused Strategies - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Can Indaptus Therapeutics Inc. stock double in next 5 yearsSwing Trade & Expert Curated Trade Setups - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Is Indaptus Therapeutics Inc. stock ready for a breakoutWeekly Stock Recap & Technical Buy Zone Confirmations - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Key resistance and support levels for Indaptus Therapeutics Inc.Weekly Profit Summary & Community Verified Watchlist Alerts - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Exit strategy if you’re trapped in Indaptus Therapeutics Inc.Weekly Volume Report & High Yield Equity Trading Tips - newser.com

Nov 15, 2025
pulisher
Nov 14, 2025

Is Indaptus Therapeutics Inc. stock a defensive play in 2025Insider Buying & AI Forecasted Stock Moves - Fundação Cultural do Pará

Nov 14, 2025
$39.25
price down icon 0.36%
$100.44
price down icon 0.47%
$33.72
price up icon 0.21%
$95.03
price up icon 0.95%
biotechnology ONC
$311.73
price down icon 0.19%
$177.42
price up icon 0.37%
Capitalizzazione:     |  Volume (24 ore):